Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brizel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2005
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyMarianne Nordsmark, Søren M Bentzen, Volker Rudat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 8, 2008
NCCN Task Force Report. prevention and management of mucositis in cancer careWilliam Bensinger, Mark Schubert, Kie-Kian Ang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2005
Head and neck cancersArlene A Forastiere, Kian Ang, David Brizel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
Head and neck cancers, Arlene A Forastiere, Kie-Kian Ang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 16, 2005
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyMarianne Nordsmark, Søren M Bentzen, Volker Rudat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 8, 2008
NCCN Task Force Report. prevention and management of mucositis in cancer careWilliam Bensinger, Mark Schubert, Kie-Kian Ang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2005
Head and neck cancersArlene A Forastiere, Kian Ang, David Brizel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 12, 2008
Head and neck cancers, Arlene A Forastiere, Kie-Kian Ang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Pageof 2